199 related articles for article (PubMed ID: 27214509)
1. Synthesis, characterization and antitubercular activities of novel pyrrolyl hydrazones and their Cu-complexes.
Joshi SD; Kumar D; Dixit SR; Tigadi N; More UA; Lherbet C; Aminabhavi TM; Yang KS
Eur J Med Chem; 2016 Oct; 121():21-39. PubMed ID: 27214509
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties.
Joshi SD; Dixit SR; Kirankumar MN; Aminabhavi TM; Raju KV; Narayan R; Lherbet C; Yang KS
Eur J Med Chem; 2016 Jan; 107():133-52. PubMed ID: 26580979
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents.
Correia I; Adão P; Roy S; Wahba M; Matos C; Maurya MR; Marques F; Pavan FR; Leite CQF; Avecilla F; Costa Pessoa J
J Inorg Biochem; 2014 Dec; 141():83-93. PubMed ID: 25226436
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of copper(II) complexes with isoniazid-derived hydrazones as anticancer and antitubercular agents.
Firmino GS; de Souza MV; Pessoa C; Lourenco MC; Resende JA; Lessa JA
Biometals; 2016 Dec; 29(6):953-963. PubMed ID: 27591998
[TBL] [Abstract][Full Text] [Related]
5. Novel Aminopyrazole Tagged Hydrazones as Anti-Tubercular Agents: Synthesis and Molecular Docking Studies.
Padmini T; Bhikshapathi D; Suresh K; Kulkarni R; Kamal BR
Med Chem; 2021; 17(4):344-351. PubMed ID: 32407282
[TBL] [Abstract][Full Text] [Related]
6. Novel copper(II) complexes with hydrazides and heterocyclic bases: Synthesis, structure and biological studies.
Paixão DA; Marzano IM; Jaimes EHL; Pivatto M; Campos DL; Pavan FR; Deflon VM; Maia PIDS; Da Costa Ferreira AM; Uehara IA; Silva MJB; Botelho FV; Pereira-Maia EC; Guilardi S; Guerra W
J Inorg Biochem; 2017 Jul; 172():138-146. PubMed ID: 28463762
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimycobacterial activities of some new thiazolylhydrazone derivatives.
Ozadali K; Tan OU; Yogeeswari P; Dharmarajan S; Balkan A
Bioorg Med Chem Lett; 2014 Apr; 24(7):1695-7. PubMed ID: 24631185
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro antitubercular activity of ferrocene-based hydrazones.
Mahajan A; Kremer L; Louw S; Guérardel Y; Chibale K; Biot C
Bioorg Med Chem Lett; 2011 May; 21(10):2866-8. PubMed ID: 21507641
[TBL] [Abstract][Full Text] [Related]
9. Copper(II) complexes based on thiosemicarbazone ligand: Preparation, crystal structure, Hirshfeld surface, energy framework, antiMycobacterium activity, in silico and molecular docking studies.
Souza RAC; Costa WRP; de F Faria E; Bessa MAS; Menezes RD; Martins CHG; Maia PIS; Deflon VM; Oliveira CG
J Inorg Biochem; 2021 Oct; 223():111543. PubMed ID: 34298306
[TBL] [Abstract][Full Text] [Related]
10. New bithiazolyl hydrazones: Novel synthesis, characterization and antitubercular evaluation.
Bhalerao MB; Dhumal ST; Deshmukh AR; Nawale LU; Khedkar V; Sarkar D; Mane RA
Bioorg Med Chem Lett; 2017 Jan; 27(2):288-294. PubMed ID: 27914801
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, molecular docking and 3D-QSAR studies of potent inhibitors of enoyl-acyl carrier protein reductase as potential antimycobacterial agents.
More UA; Joshi SD; Aminabhavi TM; Gadad AK; Nadagouda MN; Kulkarni VH
Eur J Med Chem; 2014 Jan; 71():199-218. PubMed ID: 24292339
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterisation and antitubercular activities of a series of pyruvate-containing aroylhydrazones and their Cu-complexes.
Jamadar A; Duhme-Klair AK; Vemuri K; Sritharan M; Dandawate P; Padhye S
Dalton Trans; 2012 Aug; 41(30):9192-201. PubMed ID: 22717728
[TBL] [Abstract][Full Text] [Related]
13. N-(chroman-4-ylidene)aryloxyacetohydrazones: synthesis and antimicrobial activity.
Turan-Zitouni G; Kaplancikli ZA; Güven K
Farmaco; 1997 Oct; 52(10):631-3. PubMed ID: 9507676
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization and anti-microbial evaluation of Cu(II), Ni(II), Pt(II) and Pd(II) sulfonylhydrazone complexes; 2D-QSAR analysis of Ni(II) complexes of sulfonylhydrazone derivatives.
Özbek N; Alyar S; Alyar H; Şahin E; Karacan N
Spectrochim Acta A Mol Biomol Spectrosc; 2013 May; 108():123-32. PubMed ID: 23466322
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of novel hydrazide-hydrazones and the study of their structure-antituberculosis activity.
Bedia KK; Elçin O; Seda U; Fatma K; Nathaly S; Sevim R; Dimoglo A
Eur J Med Chem; 2006 Nov; 41(11):1253-61. PubMed ID: 16919372
[TBL] [Abstract][Full Text] [Related]
16. Microwave and conventional synthesis of Co (II), Cu (II) and Ni (II) metal complexes of some acid hydrazones with their spectral characterization and biological evaluation.
Jabeen M; Mehmood K; Khan MA; Aslam N; Zafar AM; Sajid N; Noreen S; Aslam S; Ghafoor A
Pak J Pharm Sci; 2018 May; 31(3(Supplementary)):1003-1011. PubMed ID: 29731437
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization and pharmacological studies of copper complexes of flavone derivatives as potential anti-tuberculosis agents.
Joseph J; Nagashri K; Suman A
J Photochem Photobiol B; 2016 Sep; 162():125-145. PubMed ID: 27371912
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anti-mycobacterial activity of 4-(4-phenyl-1H-1,2,3-triazol-1-yl)salicylhydrazones: revitalizing an old drug.
Abdu-Allah HH; Youssif BG; Abdelrahman MH; Abdel-Hamid MK; Reshma RS; Yogeeswari P; Aboul-Fadl T; Sriram D
Arch Pharm Res; 2017 Feb; 40(2):168-179. PubMed ID: 28028696
[TBL] [Abstract][Full Text] [Related]
19. Chemical synthesis and in silico molecular modeling of novel pyrrolyl benzohydrazide derivatives: Their biological evaluation against enoyl ACP reductase (InhA) and Mycobacterium tuberculosis.
Joshi SD; More UA; Dixit SR; Balmi SV; Kulkarni BG; Ullagaddi G; Lherbet C; Aminabhavi TM
Bioorg Chem; 2017 Dec; 75():181-200. PubMed ID: 28961440
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and 2D QSAR study of novel pyridine and quinolone hydrazone derivatives as potential antimicrobial and antitubercular agents.
Abdelrahman MA; Salama I; Gomaa MS; Elaasser MM; Abdel-Aziz MM; Soliman DH
Eur J Med Chem; 2017 Sep; 138():698-714. PubMed ID: 28715707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
